Device
Whole Exome Sequencing (WES)
Whole Exome Sequencing (WES) is a medical device with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
50%(1 trials)
Phase Distribution
Ph not_applicable
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Recruiting2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed250%
recruiting250%
Recent Activity
2 active trials
Showing 4 of 4
recruitingnot_applicable
Genomic Profiling of Genetic and Rare Diseases
NCT06926127
recruitingnot_applicable
Genetic Diagnosis and Personalized Medicine for Patients With Epilepsy
NCT06321822
completednot_applicable
Clinical Utility of Prenatal Whole Exome Sequencing
NCT03482141
completed
Whole Exome Sequencing in Prenatal Diagnosis of Agenesis of the Corpus Callosum
NCT03600792
Clinical Trials (4)
Showing 4 of 4 trials
NCT06926127Not Applicable
Genomic Profiling of Genetic and Rare Diseases
NCT06321822Not Applicable
Genetic Diagnosis and Personalized Medicine for Patients With Epilepsy
NCT03482141Not Applicable
Clinical Utility of Prenatal Whole Exome Sequencing
NCT03600792
Whole Exome Sequencing in Prenatal Diagnosis of Agenesis of the Corpus Callosum
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4